OBJECTIVE: We previously demonstrated that a strategy of co-immunizing cynomologous macaques with a simian/human immunodeficiency virus DNA-based vaccine and a plasmid encoding macaque interleukin (IL)-15 induces a strong CD8 and CD4 effector T-cell response that, upon subsequent challenge with SHIV89.6P, controls viral replication and protects immunized animals against ongoing infection. In this follow-up study, we measured viral replication 2 years after vaccination challenge and determined the mechanism by which antigen-specific CD8 T cells suppress viral replication. METHOD: From the original group of 18, we assessed the immune response in the 13 surviving animals. In addition, using cM-T807, we depleted CD8 lymphocytes to assess the role CD8 cells play in suppression of viral replication. RESULT: We found that peripheral blood mononuclear cells from vaccinated animals had a robust simian immunodeficiency virus Gag-specific IFN-gamma response. In addition, in the DNA and IL-15 group, we observed higher levels of simian immunodeficiency virus Gag-specific, proliferating CD8 T cells. The profile of these cells revealed more central memory than effector cells. When we transiently depleted animals of CD8 T cells, plasma viral load increased, and peak viral load was lower in the DNA and IL-15 group compared with the DNA alone and control groups. As CD8 T cells recovered, viral replication was controlled and we observed an increase in the number of antigen-specific effector CD8 T cells. CONCLUSION: We conclude that co-immunization with a simian/human immunodeficiency virus DNA-based vaccine and IL-15 achieves sustained viral suppression and that vaccine-induced CD8 memory T cells, which differentiate into effector cells, are central to that suppression.
OBJECTIVE: We previously demonstrated that a strategy of co-immunizing cynomologous macaques with a simian/human immunodeficiency virus DNA-based vaccine and a plasmid encoding macaque interleukin (IL)-15 induces a strong CD8 and CD4 effector T-cell response that, upon subsequent challenge with SHIV89.6P, controls viral replication and protects immunized animals against ongoing infection. In this follow-up study, we measured viral replication 2 years after vaccination challenge and determined the mechanism by which antigen-specific CD8 T cells suppress viral replication. METHOD: From the original group of 18, we assessed the immune response in the 13 surviving animals. In addition, using cM-T807, we depleted CD8 lymphocytes to assess the role CD8 cells play in suppression of viral replication. RESULT: We found that peripheral blood mononuclear cells from vaccinated animals had a robust simian immunodeficiency virus Gag-specific IFN-gamma response. In addition, in the DNA and IL-15 group, we observed higher levels of simian immunodeficiency virus Gag-specific, proliferating CD8 T cells. The profile of these cells revealed more central memory than effector cells. When we transiently depleted animals of CD8 T cells, plasma viral load increased, and peak viral load was lower in the DNA and IL-15 group compared with the DNA alone and control groups. As CD8 T cells recovered, viral replication was controlled and we observed an increase in the number of antigen-specific effector CD8 T cells. CONCLUSION: We conclude that co-immunization with a simian/human immunodeficiency virus DNA-based vaccine and IL-15 achieves sustained viral suppression and that vaccine-induced CD8 memory T cells, which differentiate into effector cells, are central to that suppression.
Authors: Jiangmei Yin; Anlan Dai; Tatiana Arango; Ravi S Kasinathan; Robert M Greenberg; Jean D Boyer Journal: Hum Vaccin Immunother Date: 2012-11-01 Impact factor: 3.452
Authors: Raj Kurupati; Steve Tuyishime; Andrew V Kossenkov; Marina Sazanovich; Larissa H Haut; Marcio O Lasaro; Sarah J Ratcliffe; Steven E Bosinger; Diane G Carnathan; Mark Lewis; Louise C Showe; Guido Silvestri; Hildegund C J Ertl Journal: J Leukoc Biol Date: 2012-12-27 Impact factor: 4.962
Authors: Jiangmei Yin; Maryanne T Vahey; Anlan Dai; Mark G Lewis; Tatiana Arango; Jake Yalley-Ogunro; Jack Greenhouse; Karla Mendoza; Amir Khan; Niranjan Y Sardesai; Walter Weiss; Jack Komisar; Jean D Boyer Journal: J Infect Dis Date: 2012-06-12 Impact factor: 5.226
Authors: Yvonne M Mueller; Duc H Do; Jean D Boyer; Muhamuda Kader; Joseph J Mattapallil; Mark G Lewis; David B Weiner; Peter D Katsikis Journal: J Immunol Date: 2009-09-28 Impact factor: 5.422
Authors: Jiangmei Yin; Anlan Dai; Dominick J Laddy; Jian Yan; Tatiana Arango; Amir S Khan; Mark G Lewis; Hanne Andersen; Michele A Kutzler; Ruxandra Draghia-Akli; David B Weiner; Jean D Boyer Journal: Virology Date: 2009-08-15 Impact factor: 3.616
Authors: Robert A Dubie; Saipiroon Maksaereekul; Barbara L Shacklett; Donna Lemongello; Kelly S Cole; Francois Villinger; Shelley A Blozis; Paul A Luciw; Ellen E Sparger Journal: Virology Date: 2009-02-03 Impact factor: 3.616